Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Quality Assurance Manager

Nova 401(k) Associates
(Remote)

Nova 401(k) Associates logo

Education Consultant

Pentegra
(Remote / Putnam Valley NY)

Pentegra logo

Retirement Plan Analyst/Administrator

Compensation Strategies Group, Ltd.
(Remote / Beaumont TX)

Compensation Strategies Group, Ltd. logo

Retirement Plan Administrator

Nicholas Pension Consultants
(Remote / Corona CA / Rancho Cordova CA)

Nicholas Pension Consultants logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile App image LinkedIn icon
Twitter icon
Facebook icon

<< Previous news item   |   Next news item >>



Report of House Committee on Oversight and Reform: Drug Pricing Investigation (PDF)
Committee on Oversight and Government Reform, U.S. House of RepresentativesLink to more items from this source
Dec. 23, 2021

269 pages. "Although the markets for these products differ, the Committee uncovered common practices that cut across the industry. First, drug companies have raised prices with abandon, especially when they succeed in delaying or blocking competition.... Second, companies have manipulated the patent system and marketing exclusivities granted by the [FDA] to extend their monopolies far longer than lawmakers envisioned when they created these systems.... Third, all the companies the Committee investigated have employed anticompetitive strategies to suppress generic competition.... These practices persist because the highly complex U.S. pharmaceutical market creates perverse incentives to raise prices, and unlike in other countries, drug companies can do so without limitation."

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).
An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).
© 2022 BenefitsLink.com, Inc.